Northern Trust’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-21,461
Closed -$14.4K 4595
2023
Q2
$14.4K Hold
21,461
﹤0.01% 4449
2023
Q1
$29.8K Sell
21,461
-46
-0.2% -$87 ﹤0.01% 4374
2022
Q4
$27.1K Sell
21,507
-497
-2% -$1.13K ﹤0.01% 4419
2022
Q3
$94K Sell
22,004
-502
-2% -$2.49K ﹤0.01% 4132
2022
Q2
$117K Sell
22,506
-80,372
-78% -$757K ﹤0.01% 4114
2022
Q1
$1.23M Sell
102,878
-3,948
-4% -$53.9K ﹤0.01% 3329
2021
Q4
$2.09M Buy
106,826
+2,168
+2% +$48.5K ﹤0.01% 3199
2021
Q3
$2.72M Buy
104,658
+68,006
+186% +$1.6M ﹤0.01% 3116
2021
Q2
$806K Buy
36,652
+20,615
+129% +$506K ﹤0.01% 3582
2021
Q1
$375K Buy
16,037
+5,402
+51% +$166K ﹤0.01% 3911
2020
Q4
$183K Buy
10,635
+4,571
+75% +$76.3K ﹤0.01% 3988
2020
Q3
$99K Buy
6,064
+4,002
+194% +$48.5K ﹤0.01% 3969
2020
Q2
$24K Hold
2,062
﹤0.01% 4150
2020
Q1
$21K Hold
2,062
﹤0.01% 4086
2019
Q4
$23K Buy
2,062
+686
+50% +$11.4K ﹤0.01% 4149
2019
Q3
$29K Sell
1,376
-8,297
-86% -$168K ﹤0.01% 4126
2019
Q2
$224K Sell
9,673
-1,308
-12% -$39.2K ﹤0.01% 3789
2019
Q1
$424K Buy
10,981
+621
+6% +$26.9K ﹤0.01% 3581
2018
Q4
$479K Buy
10,360
+11
+0.1% +$815 ﹤0.01% 3558
2018
Q3
$1.41M Buy
10,349
+9,224
+820% +$1.58M ﹤0.01% 3366
2018
Q2
$530K Buy
+1,125
New +$414K ﹤0.01% 3584
2017
Q4
Sell
-58
Closed -$8K 4276
2017
Q3
$8K Hold
58
﹤0.01% 4210
2017
Q2
$6K Hold
58
﹤0.01% 4242
2017
Q1
$14K Buy
+58
New +$17.4K ﹤0.01% 4182

Other funds holding NMTR

Northern Trust's NMTR Position: Q3 2023 in Review

Northern Trust sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 21,461 shares — an estimated $14.4K sold.

Northern Trust first reported a position in NMTR in Q1 2017 and held it in 24 quarters. The position peaked at $2.72M in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Northern Trust reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Northern Trust sold 21,461 9 Meters Biopharma shares in Q3 2023, an estimated $14.4K.
  • Northern Trust first reported a position in 9 Meters Biopharma in Q1 2017 and held it in 24 quarters.
  • Northern Trust's 9 Meters Biopharma position peaked at $2.72M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.